Wyo. Code R. 015-0015-1
Effective Date: 11/16/2015 to 03/10/2016
Rule Type: Expired Emergency Rules & Regulations
Reference Number: 015.0015.1.11162015
Section 1. Purpose. The purpose of these rules is to add, delete, and reschedule controlled substances in the Wyoming Controlled Substances Act of 1971. Some changes will be made to similarly control a substance in response to the publication of a final order in the Federal Register designating that substance as a controlled substance under federal law. Other changes will be made at the discretion of the Wyoming Attorney General, in his capacity as the Commissioner of Drugs and Substances Control, with the advice of the Advisory Board on Drugs and Substances Control.
Section 2. Authority. The Commissioner of Drugs and Substances Control's rulemaking authority is found at Wyoming Statute § 35-7-1011(a) and (d), which allow the Commissioner to add, delete, and reschedule substances to the control schedules pursuant to the procedures of the Wyoming Administrative Procedure Act.
Section 3. First Additional Controlled Substances. The United States Drug Enforcement Administration published in the Federal Register a final order designating a new compound as a Schedule I controlled substance. Pursuant to Wyoming Statute § 35-7-1011(d), the Commissioner of Drugs and Substances Control adds the following substance to Schedule I:
(a) The Commissioner incorporates by reference 21 CFR Part 1308, found at Federal Register Vol. 80, No. 137, page 42,385. The URL for the federal rule is: http://www.gpo.gov/fdsys/pkg/FR-2015-07-17/pdf/2015-17563.pdf (last visited September 17, 2015). This Section does not include any later amendments or additions to the Federal rule for Schedule I controlled substances.
Section 4. Second Additional Controlled Substances. The Commissioner of Drugs and Substances Control, acting with the advice of the Advisory Board on Drugs and Substances Control, adds the following substances to Schedule I:
(a) Synthetic cannabinoid: (S)-methyl2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, commonly known as 5F-AMB;
(b) Synthetic cannabinoid: [N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide, commonly known as ADB-FUBINACA.